Company Overview
Snapshot
Founded in December 2008 by Eyal Orion, Vascular Graft Solutions operates with 11–50 employees. The company has raised $4.8 million across six funding rounds from five investors. In January 2020, Vascular Graft Solutions acquired the intellectual property developed by Kipsbay Medical Inc.
Business overview
Vascular Graft Solutions (VGS) develops technologies aimed at improving surgical revascularization, vascular reconstruction procedures, and arteriovenous fistulas. Its product portfolio includes VEST, an external support for vein grafts in coronary artery bypass surgery, and FRAME, an external support for vein grafts in peripheral revascularization and reconstruction procedures. These devices are designed to address factors contributing to saphenous vein graft disease, such as disturbed flow patterns, high wall tension, diameter mismatch, and intimal hyperplasia. The company serves the medical devices and medical treatment & therapeutics sectors within the healthcare industry.
Strategic signal
In January 2020, Vascular Graft Solutions acquired the intellectual property developed by Kipsbay Medical Inc. This acquisition signals a strategic move to expand its technological foundation and product pipeline, potentially enhancing its competitive position in the cardiovascular medical device market. For investors, this indicates a proactive approach to growth through inorganic means, aiming to integrate new innovations into its existing offerings.
Company Intelligence Q&A
- What is Vascular Graft Solutions' primary focus?
- Vascular Graft Solutions focuses on developing technologies to improve surgical revascularization, vascular reconstruction procedures, and arteriovenous fistulas, primarily through external support devices for vein grafts.
- When did Vascular Graft Solutions acquire intellectual property from Kipsbay Medical Inc.?
- In January 2020, Vascular Graft Solutions acquired the intellectual property developed by Kipsbay Medical Inc.
- What is the VEST technology?
- VEST is an external support device developed by Vascular Graft Solutions for vein grafts used in coronary artery bypass surgery. It received CE mark approval in 2014 and is commercialized in international markets.
- What is the FRAME technology?
- FRAME is an external support device developed by Vascular Graft Solutions for vein grafts in peripheral revascularization and reconstruction procedures. It received CE mark approval in late 2017 and is commercialized for various indications, including bypass surgeries and peripheral aneurysm repair.